Zhiqiang Han Selected Research

Zhiqiang Han Research Topics

Disease

22	Neoplasms (Cancer) 12/2022 - 01/2004
11	Ovarian Neoplasms (Ovarian Cancer) 06/2014 - 01/2004
8	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2005
4	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2008
3	Infections 01/2020 - 06/2013
3	Prostatic Neoplasms (Prostate Cancer) 09/2014 - 06/2007
2	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 11/2016
2	Carcinoma (Carcinomatosis) 01/2020 - 02/2006
2	Melanoma (Melanoma, Malignant) 09/2015 - 11/2011
2	Leukemia 10/2011 - 08/2009
2	Carcinogenesis 01/2011 - 02/2006
1	Hepatoblastoma 12/2022
1	Congenital Abnormalities (Deformity) 03/2022
1	Cleft Lip (Harelip) 03/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2021
1	Polycythemia Vera 01/2020
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Splenomegaly 01/2020
1	Necrosis 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 11/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2011
1	Virus Diseases (Viral Diseases) 12/2009
1	Starvation 10/2009

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 12/2022 - 02/2006
5	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 09/2011
4	Biological ProductsIBA 11/2016 - 01/2007
3	Interleukin-6 (Interleukin 6)IBA 09/2014 - 05/2013
3	Small Interfering RNA (siRNA)IBA 12/2013 - 03/2008
2	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2016
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2005
2	statticIBA 09/2014 - 12/2013
2	Complementary DNA (cDNA)IBA 11/2011 - 12/2009
2	VimentinIBA 01/2008 - 06/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022
1	Sincalide FDA Link 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	CholesterolIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	ChromatinIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	InterferonsIBA 01/2020
1	olaparibIBA 01/2020
1	ruxolitinibIBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 12/2016
1	Interleukin-10 (Interleukin 10)IBA 09/2015
1	Interleukin-10 ReceptorsIBA 09/2015
1	Aldehyde DehydrogenaseIBA 09/2014
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2014
1	HeterochromatinIBA 06/2014
1	SurvivinIBA 12/2013
1	GTP Phosphohydrolases (GTPases)IBA 08/2013
1	Fibronectins (Fibronectin)IBA 08/2013
1	EucalyptolIBA 06/2013
1	LimoneneIBA 06/2013
1	Volatile Oils (Essential Oils)IBA 06/2013
1	zingibereneIBA 06/2013
1	citronellalIBA 06/2013
1	PlatinumIBA 05/2013
1	Peptides (Polypeptides)IBA 11/2011
1	Amyloid (Amyloid Fibrils)IBA 11/2011
1	ferric ferrocyanide (Prussian blue)FDA Link 11/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2011
1	TOR Serine-Threonine KinasesIBA 10/2011
1	PI103IBA 10/2011
1	ArsenicIBA 10/2011
1	Aligeron (AS 2)IBA 10/2011
1	arsenic disulfide (realgar)IBA 10/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2011
1	Biomarkers (Surrogate Marker)IBA 09/2011
1	Caspase 3 (Caspase-3)IBA 01/2011
1	Death Domain ReceptorsIBA 01/2011
1	Caspase 8 (Caspase-8)IBA 01/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2009
1	Amino Acids FDA Link 10/2009
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2009
1	theasinensin AIBA 08/2009
1	Histone Deacetylase InhibitorsIBA 08/2009
1	trichostatin A (A 300)IBA 08/2009
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 10/2008
1	Potassium Channels (Potassium Channel)IBA 10/2008

Therapy/Procedure

10	Therapeutics 04/2022 - 02/2006
5	Drug Therapy (Chemotherapy) 04/2021 - 01/2012
3	Immunotherapy 02/2022 - 04/2021
2	Proton Therapy 01/2020 - 11/2016
1	Transplantation 03/2022
1	Molecular Targeted Therapy 04/2021
1	Chemoprevention 01/2020
1	Radiotherapy 11/2016
1	Intravenous Injections 11/2011
1	Aftercare (After-Treatment) 08/2009